Masayoshi Iwamoto

966 citations
24 papers · 775 indexed · h-index 12
Topics
Colorectal Cancer Surgical Treatments (9 papers)Cancer, Hypoxia, and Metabolism (4 papers)Chemokine receptors and signaling (4 papers)
Partner nations
JapanUnited States

In The Last Decade

Masayoshi Iwamoto

22 papers receiving 767 citations

Peers

Masayoshi Iwamoto
Comparison fields: 5 of 70
  • Oncology 414
  • Molecular Biology 314
  • Immunology 220
  • Cancer Research 219
  • Surgery 75
Replace Cuiju Tang with:
Cuiju Tang China
Hiroaki Kasashima Japan
Susumu Inamoto Japan
Chun-Tao Wu China
Mitsukazu Gotoh Japan
Yanwei Shen China
Brian Riesenberg United States
Masaaki Miyo Japan
Remi Adelaiye‐Ogala United States
Masayoshi Iwamoto relative to Cuiju Tang China Cuiju Tang's profile →
Citations per field
00.5×1.5×2.5×
Cuiju Tang · 1×
Citations per year

Countries citing papers authored by Masayoshi Iwamoto

Since Specialization
Citations

This map shows the geographic impact of Masayoshi Iwamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masayoshi Iwamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masayoshi Iwamoto more than expected).

Fields of papers citing papers by Masayoshi Iwamoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masayoshi Iwamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masayoshi Iwamoto. The network helps show where Masayoshi Iwamoto may publish in the future.

Co-authorship network of co-authors of Masayoshi Iwamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Masayoshi Iwamoto. A scholar is included among the top collaborators of Masayoshi Iwamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masayoshi Iwamoto. Masayoshi Iwamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 0
3 1
4 3
5 4
6 11
7 3
8 4
9 1
10 8
11 1
12 11
13 75
14 97
15 106
16 42
17 63
18 108
19 115
20 23

About Masayoshi Iwamoto

Masayoshi Iwamoto is a scholar working on Oncology, Cancer Research and Surgery, having authored 24 papers that have together received 775 indexed citations. Recurring topics across this work include Colorectal Cancer Surgical Treatments (9 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Chemokine receptors and signaling (4 papers). The work is most often cited by research in Oncology (414 citations), Cancer Research (219 citations) and Immunology (220 citations). Masayoshi Iwamoto has collaborated with scholars based in Japan and United States. Frequent co-authors include Yoshiharu Sakai, Kenji Kawada, Suguru Hasegawa, Susumu Inamoto, Yoshiro Itatani, Makoto M. Taketo, Kosuke Toda, Hideyo Hirai, Takehiko Sasazuki and Senji Shirasawa. Their work appears in journals such as Gastroenterology, Scientific Reports and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026